Algal Bio Co., Ltd.
PrivateLast Round
Series B
Dec 28, 2022
Est. Valuation
$26.64M
Total Funding Raised
$17.52M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Algal Bio Co., Ltd. operates in Healthcare & Life Sciences and is based in Kashiwa. Its latest recorded funding round was a Series B round in December 2022.
Algal Bio Co., Ltd. is a biotechnology company that operates an algae bio-foundry platform for applying algae in various industries to address health, food, and environmental issues.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Carbon Capture
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Algal Bio Co., Ltd. Comparables
Compare Algal Bio Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlgoSource | 78% | |
| Kuehnle AgroSystems Inc. | 76% | |
| Phytolipid Technologies | 76% |
For institutional investors. Book with your work email.
Algal Bio Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 28, 2022 | ||||
| Series B | Jul 26, 2022 | ||||
| Grant | Jul 1, 2020 | ||||
| Series A | Nov 29, 2019 | ||||
| Seed | Apr 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Algal Bio Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abies Ventures | Series B, Series A |
| Mizuho Capital | Series B |
| UTEC (The University of Tokyo Edge Capital Partners) | Series B, Seed, Series A |
| New Energy and Industrial Technology Development Organization | Grant |
| Chibagin Capital | Series A |
| 株式会社常陽キャピタルパートナーズ | Series B |
| Joyo Capital Partners | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 67% MoM.
- Jul 26, 2022
$7M round led by DBJ Capital and UTEC.
For institutional investors. Book with your work email.
Algal Bio Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Algal Bio Co., Ltd.'s valuation, stock price, and market status.
Is Algal Bio Co., Ltd. a public or private company?
Algal Bio Co., Ltd. is a private company.
What is the current stock price of Algal Bio Co., Ltd.?
Algal Bio Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Algal Bio Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Algal Bio Co., Ltd. worth (valuation)?
Algal Bio Co., Ltd.'s valuation is estimated at $26.6M based on funding round data.
Can I buy Algal Bio Co., Ltd. stock?
Algal Bio Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Algal Bio Co., Ltd.'s last funding round?
Algal Bio Co., Ltd.'s most recent funding round was Series B on December 28, 2022.
Who are the main investors in Algal Bio Co., Ltd.?
Key investors in Algal Bio Co., Ltd. include UTEC (The University of Tokyo Edge Capital Partners), DBJ Capital.
Will Algal Bio Co., Ltd. IPO soon?
No public IPO plans have been announced for Algal Bio Co., Ltd..
How can I track Algal Bio Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Algal Bio Co., Ltd.'s shares on secondary markets.